Compare Summit Therapeutics Inc (SMMT) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Virgin Galactic Holdings, Inc. trades at $2.78 (market cap $329.06M). The key difference: Summit Therapeutics Inc is far larger — about 31.8× Virgin Galactic Holdings, Inc.'s market cap. Which is the better fit depends on your goals.
| SMMT | SPCE | |
|---|---|---|
Market Cap | $10.48B | $329.06M |
Sector | Health | Industrials |
52-Week High | $29.32 | $7.52 |
52-Week Low | $13.05 | $2.17 |
Enterprise Value | $9.90B | $428.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
